New drug aims to unclog Alzheimer's brain, trial underway
Disease control
Ongoing
This study tests a new drug called PRI-002 in 304 people with early Alzheimer's (mild cognitive impairment or mild dementia). The drug is designed to break apart small sticky protein clumps in the brain that are thought to cause memory and thinking problems. The goal is to see if…
Phase: PHASE2 • Sponsor: PRInnovation GmbH • Aim: Disease control
Last updated May 04, 2026 16:19 UTC